Suppr超能文献

印度人群的健康相关生活质量:印度 EQ-5D 人群正常值。

Health-related quality of life among Indian population: The EQ-5D population norms for India.

机构信息

Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

National Health Authority, Ministry of Health and Family Welfare, Government of India, New Delhi, India.

出版信息

J Glob Health. 2023 Feb 17;13:04018. doi: 10.7189/jogh.13.04018.

Abstract

BACKGROUND

The EuroQol 5 dimensions (EQ-5D) is the most used generic health-related quality of life (HRQoL) instrument for measuring population health and health outcomes. Since there are no EuroQol 5 dimensions 5 levels (EQ-5D-5L) population norms available for India, this study developed the Indian population norms for the EQ-5D-5L. The potential influencing factors of HRQoL of the Indian population have been identified.

METHODS

The data was collected alongside the Indian EQ-5D-5L valuation study (Development of an EQ-5D Value Set for India Using an Extended Design: DEVINE Study). A cross-sectional survey of 3548 adult respondents was conducted across five states of India, in which respondents were asked to report their own health states using the EQ-5D-5L descriptive system and the EuroQol Visual Analog Scale (EQ VAS). The utility score was calculated using the EQ-5D-5L value set based on the preferences of the Indian population. Norm scores were generated for age, sex, and other important socio-demographic variables. The proportion of patients reporting problems in different dimensions of EQ-5D-5L was assessed. The impact of socio-economic determinants on health-related quality of life was evaluated using multiple linear regression.

RESULTS

The mean EQ VAS score of the Indian population is 75.18 (95% confidence interval (CI) = 74.50-75.90), whereas mean utility score is 0.848 (95% CI = 0.840-0.857). The EQ VAS scores, and utility scores decreased with age. Males reported higher EQ VAS values than females. The highest mean utility score was observed for males of <20 years (0.936), whereas the lowest mean score was observed for females of >70 years (0.488). The mean VAS score ranged between 85.24 for females of <20 years and 50.67 for females of >70 years. Highest problems were reported in the dimension of "pain / discomfort", closely followed by "anxiety / depression". Age, educational qualification, marital status, substance abuse, presence of ailments, state / region of residence, number of dependent members in the household, and time spent on mobile are the significant determinants of HRQoL of Indian population.

CONCLUSIONS

These population norms will be used as reference values for comparative purposes in future Indian studies. Economic evaluations can use these average age-specific HRQoL population norms to value the health-state of not having the specific disease under investigation.

摘要

背景

EuroQol 5 维度(EQ-5D)是最常用于衡量人群健康和健康结果的通用健康相关生活质量(HRQoL)工具。由于印度没有可用的 EuroQol 5 维度 5 级(EQ-5D-5L)人群标准,因此本研究制定了 EQ-5D-5L 的印度人群标准。已经确定了影响印度人群 HRQoL 的潜在因素。

方法

数据是在印度 EQ-5D-5L 估值研究(使用扩展设计开发印度 EQ-5D 值集:DEVINE 研究)中收集的。在印度五个邦进行了一项横断面调查,共调查了 3548 名成年受访者,要求受访者使用 EQ-5D-5L 描述系统和 EuroQol 视觉模拟量表(EQ VAS)报告自己的健康状况。使用基于印度人群偏好的 EQ-5D-5L 值集计算效用得分。生成了年龄、性别和其他重要社会人口统计学变量的标准得分。评估了 EQ-5D-5L 不同维度中报告存在问题的患者比例。使用多元线性回归评估社会经济决定因素对健康相关生活质量的影响。

结果

印度人群的平均 EQ VAS 得分为 75.18(95%置信区间(CI)=74.50-75.90),平均效用得分为 0.848(95%CI=0.840-0.857)。EQ VAS 评分和效用评分随年龄增长而下降。男性的 EQ VAS 值报告高于女性。20 岁以下男性的平均效用得分最高(0.936),而 70 岁以上女性的平均得分最低(0.488)。VAS 评分的平均值在 20 岁以下女性的 85.24 到 70 岁以上女性的 50.67 之间。报告的最高问题出现在“疼痛/不适”维度,其次是“焦虑/抑郁”。年龄、教育程度、婚姻状况、物质滥用、疾病存在、居住州/地区、家庭中受抚养成员人数以及使用手机的时间是印度人群 HRQoL 的重要决定因素。

结论

这些人群标准将作为未来印度研究的比较参考值使用。经济评估可以使用这些特定年龄的平均 HRQoL 人群标准来衡量特定疾病未发生的健康状态。

相似文献

1
Health-related quality of life among Indian population: The EQ-5D population norms for India.
J Glob Health. 2023 Feb 17;13:04018. doi: 10.7189/jogh.13.04018.
2
Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
Health Qual Life Outcomes. 2016 Sep 20;14(1):133. doi: 10.1186/s12955-016-0537-0.
3
EQ-5D-5L norms for the urban Chinese population in China.
Health Qual Life Outcomes. 2018 Nov 8;16(1):210. doi: 10.1186/s12955-018-1036-2.
4
Population norms of health-related quality of life in Moscow, Russia: the EQ-5D-5L-based survey.
Qual Life Res. 2021 Mar;30(3):831-840. doi: 10.1007/s11136-020-02705-0. Epub 2020 Nov 25.
6
New Zealand Population Norms for the EQ-5D-5L Constructed From the Personal Value Sets of Participants in a National Survey.
Value Health. 2021 Sep;24(9):1308-1318. doi: 10.1016/j.jval.2021.04.1280. Epub 2021 Jun 26.
7
EQ-5D-5L Slovenian population norms.
Health Qual Life Outcomes. 2020 Oct 7;18(1):333. doi: 10.1186/s12955-020-01584-w.
8
Population norms for the EQ-5D-3L and EQ-5D-5L in Romania.
Health Qual Life Outcomes. 2023 Jul 29;21(1):80. doi: 10.1186/s12955-023-02144-8.
9
Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set.
Value Health. 2022 Jul;25(7):1218-1226. doi: 10.1016/j.jval.2021.11.1370. Epub 2022 Jan 5.
10
Danish population health measured by the EQ-5D-5L.
Scand J Public Health. 2023 Mar;51(2):241-249. doi: 10.1177/14034948211058060. Epub 2021 Nov 30.

引用本文的文献

1
Valuing health across groups: a cross-sectional population-based willingness-to-pay survey in Bhutan.
BMJ Glob Health. 2025 Aug 21;10(8):e019098. doi: 10.1136/bmjgh-2025-019098.
2
Quality of life and financial implications of depression in India.
Indian J Psychiatry. 2025 Jul;67(7):675-684. doi: 10.4103/indianjpsychiatry_170_25. Epub 2025 Jul 15.
3
Health related quality of life of tuberculosis patients in South India: A longitudinal assessment study.
PLoS One. 2025 Jul 23;20(7):e0328484. doi: 10.1371/journal.pone.0328484. eCollection 2025.
7
8
Differences in health related quality of life among older migrants and nonmigrants in India.
Sci Rep. 2025 Feb 3;15(1):4042. doi: 10.1038/s41598-025-87947-z.
10
Pain determinants and quality of life in Guillain-Barre syndrome: a prospective cohort study.
BMJ Neurol Open. 2024 Dec 11;6(2):e000925. doi: 10.1136/bmjno-2024-000925. eCollection 2024.

本文引用的文献

1
Distribution of self-reported health in India: The role of income and geography.
PLoS One. 2023 Jan 27;18(1):e0279999. doi: 10.1371/journal.pone.0279999. eCollection 2023.
2
Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set.
Value Health. 2022 Jul;25(7):1218-1226. doi: 10.1016/j.jval.2021.11.1370. Epub 2022 Jan 5.
3
Cost-effectiveness of population-based screening for diabetes and hypertension in India: an economic modelling study.
Lancet Public Health. 2022 Jan;7(1):e65-e73. doi: 10.1016/S2468-2667(21)00199-7. Epub 2021 Nov 12.
4
EQ-5D Brazilian population norms.
Health Qual Life Outcomes. 2021 Jun 10;19(1):162. doi: 10.1186/s12955-021-01671-6.
5
The performance of the EQ-5D-3L in screening for anxiety and depressive symptoms in hospital and community settings.
Health Qual Life Outcomes. 2021 Mar 19;19(1):96. doi: 10.1186/s12955-021-01731-x.
6
Health technology assessment in India: Reflection & future roadmap.
Indian J Med Res. 2020 Nov;152(5):444-447. doi: 10.4103/ijmr.IJMR_115_19.
8
Population norms of health-related quality of life in Moscow, Russia: the EQ-5D-5L-based survey.
Qual Life Res. 2021 Mar;30(3):831-840. doi: 10.1007/s11136-020-02705-0. Epub 2020 Nov 25.
9
Cost effectiveness of strategies for cervical cancer prevention in India.
PLoS One. 2020 Sep 1;15(9):e0238291. doi: 10.1371/journal.pone.0238291. eCollection 2020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验